Karyopharm Therapeutics Inc.
KPTI
$5.46
$0.101.87%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -124.62M | -123.57M | -62.52M | -76.42M | -87.48M |
| Total Depreciation and Amortization | 358.00K | 320.00K | 333.00K | 340.00K | 336.00K |
| Total Amortization of Deferred Charges | 10.46M | 10.06M | 8.73M | 6.37M | 4.23M |
| Total Other Non-Cash Items | -7.73M | -18.17M | -78.18M | -57.47M | -46.43M |
| Change in Net Operating Assets | 32.18M | 28.41M | 8.89M | -302.00K | 9.09M |
| Cash from Operations | -89.35M | -102.94M | -122.75M | -127.49M | -120.26M |
| Capital Expenditure | 53.00K | 53.00K | 53.00K | -142.00K | -195.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.12M | 55.79M | 88.77M | 95.62M | 107.71M |
| Cash from Investing | 53.18M | 55.84M | 88.82M | 95.47M | 107.52M |
| Total Debt Issued | 0.00 | 83.30M | 83.30M | 83.30M | 83.30M |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Issuance of Common Stock | 1.04M | 1.04M | 1.45M | 1.45M | 1.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -83.30M | -43.11M | -43.11M | -43.11M |
| Cash from Financing | 1.04M | 1.04M | 41.65M | 41.65M | 41.23M |
| Foreign Exchange rate Adjustments | -5.00K | 29.00K | 10.00K | -11.00K | 98.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.15M | -46.04M | 7.73M | 9.62M | 28.59M |